Paper40705771
Untargeted Diversity-Oriented Synthesis for the Discovery of New Antitumor Agents: An Integrated Approach of Inverse Virtual Screening, Bioinformatics, and Omics for Target Deconvolution.
Ciaglia T and 22 others. J Med Chem, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Untargeted Diversity-Oriented Synthesis for the Discovery of New Antitumor Agents: An Integrated Approach of Inverse Virtual Screening, Bioinformatics, and Omics for Target Deconvolution. Papers, record 40705771. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40705771
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Untargeted Diversity-Oriented Synthesis for the Discovery of New Antitumor Agents: An Integrated Approach of Inverse Virtual Screening, Bioinformatics, and Omics for Target Deconvolution.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Computational Biology | Major topic |
| Drug Discovery | Major topic |
| Humans | |
| Drug Screening Assays, Antitumor | |
| Cell Line, Tumor | |
| Apoptosis |
Source PubMed
References106
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15027865 | Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. | J Med Chem | 2004 | https://conductscience.org/library/papers/15027865 | PubMed |
| 2 | 28042841 | Facile Synthesis for Benzo-1,4-Oxazepine Derivatives by Tandem Transformation of C-N Coupling/C-H Carbonylation. | Molecules | 2016 | https://conductscience.org/library/papers/28042841 | PubMed |
| 3 | 22537682 | Inverse Virtual Screening allows the discovery of the biological activity of natural compounds. | Bioorg Med Chem | 2012 | https://conductscience.org/library/papers/22537682 | PubMed |
| 4 | 32777735 | Isocitrate dehydrogenase variants in cancer - Cellular consequences and therapeutic opportunities. | Curr Opin Chem Biol | 2020 | https://conductscience.org/library/papers/32777735 | PubMed |
| 5 | 21542600 | Inverse virtual screening of antitumor targets: pilot study on a small database of natural bioactive compounds. | J Nat Prod | 2011 | https://conductscience.org/library/papers/21542600 | PubMed |
| 6 | 32106040 | Recent advances in synthesis and medicinal chemistry of benzodiazepines. | Bioorg Chem | 2020 | https://conductscience.org/library/papers/32106040 | PubMed |
| 7 | 32796829 | BRD4 prevents the accumulation of R-loops and protects against transcription-replication collision events and DNA damage. | Nat Commun | 2020 | https://conductscience.org/library/papers/32796829 | PubMed |
| 8 | 32004460 | Cryo-EM Structure of the Human Cannabinoid Receptor CB2-Gi Signaling Complex. | Cell | 2020 | https://conductscience.org/library/papers/32004460 | PubMed |
| 9 | 28525743 | Bromodomain Protein BRD4 Is a Transcriptional Repressor of Autophagy and Lysosomal Function. | Mol Cell | 2017 | https://conductscience.org/library/papers/28525743 | PubMed |
| 10 | 26512697 | Roles of TRPM8 Ion Channels in Cancer: Proliferation, Survival, and Invasion. | Cancers (Basel) | 2015 | https://conductscience.org/library/papers/26512697 | PubMed |
| 11 | 38372253 | Novel Dual-Acting Hybrids Targeting Type-2 Cannabinoid Receptors and Cholinesterase Activity Show Neuroprotective Effects In Vitro and Amelioration of Cognitive Impairment In Vivo. | ACS Chem Neurosci | 2024 | https://conductscience.org/library/papers/38372253 | PubMed |
| 12 | 9057858 | From peptide to non-peptide. 3. Atropisomeric GPIIbIIIa antagonists containing the 3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione nucleus. | J Med Chem | 1997 | https://conductscience.org/library/papers/9057858 | PubMed |
| 13 | 27634891 | CB2 cannabinoid receptor activation promotes colon cancer progression via AKT/GSK3β signaling pathway. | Oncotarget | 2016 | https://conductscience.org/library/papers/27634891 | PubMed |
| 14 | 34572385 | Target-Oriented Synthesis of Marine Coelenterazine Derivatives with Anticancer Activity by Applying the Heavy-Atom Effect. | Biomedicines | 2021 | https://conductscience.org/library/papers/34572385 | PubMed |
| 15 | 37393347 | Transient receptor potential ankyrin 1 (TRPA1) mediates reactive oxygen species-induced Ca2+ entry, mitochondrial dysfunction, and caspase-3/7 activation in primary cultures of metastatic colorectal carcinoma cells. | Cell Death Discov | 2023 | https://conductscience.org/library/papers/37393347 | PubMed |
| 16 | 39274873 | Identification of Novel Bromodomain-Containing Protein 4 (BRD4) Binders through 3D Pharmacophore-Based Repositioning Screening Campaign. | Molecules | 2024 | https://conductscience.org/library/papers/39274873 | PubMed |
| 17 | 34039605 | BRD4 methylation by the methyltransferase SETD6 regulates selective transcription to control mRNA translation. | Sci Adv | 2021 | https://conductscience.org/library/papers/34039605 | PubMed |
| 18 | 12848532 | Discovery of an inhibitor of a transcription factor using small molecule microarrays and diversity-oriented synthesis. | J Am Chem Soc | 2003 | https://conductscience.org/library/papers/12848532 | PubMed |
| 19 | 37563469 | Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy. | Nat Metab | 2023 | https://conductscience.org/library/papers/37563469 | PubMed |
| 20 | 22067455 | SuperTarget goes quantitative: update on drug-target interactions. | Nucleic Acids Res | 2012 | https://conductscience.org/library/papers/22067455 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40705771
GET https://conductscience.org/api/papers/v1/40705771/authors?page=2